Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
about
Quantitative modeling of chronic myeloid leukemia: insights from radiobiologyLung cancer and concurrent or sequential lymphoma: Two case reports with hypersensitivity to bevacizumab and a review of the literatureRadiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer.Dosimetric advantages of a "butterfly" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphomaEfficacy of dose escalation on TCP, recurrence and second cancer risks: a mathematical study.Current knowledge and future research directions in treatment-related second primary malignancies.Applications of new irradiation modalities in patients with lymphoma: Promises and uncertainties.Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma.Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes.Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin's Lymphoma: dosimetric comparison and clinical considerationsInvolved site radiation therapy for the treatment of early-stage Hodgkin lymphoma in adolescents and young adultsRadiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating riskSecond malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.Helical tomotherapy in children and adolescents: dosimetric comparisons, opportunities and issuesA new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation.The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.Radiation-induced second malignancies after involved-node radiotherapy with deep-inspiration breath-hold technique for early stage Hodgkin Lymphoma: a dosimetric study.XVII. Radiotherapy in early stage Hodgkin lymphoma.Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?Role of Radiation Therapy in the Treatment of Hodgkin Lymphoma.Second cancer risk assessments after involved-site radiotherapy for mediastinal Hodgkin lymphoma.Improvement of dose distribution in breast radiotherapy using a reversible transverse magnetic field Linac-MR unit.Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation.Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.[IF-RT alone remains gold standard for stage IA nodular lymphocyte-predominant Hodgkin lymphoma].Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.Radiation-Induced Malignancies Making Radiotherapy a "Two-Edged Sword": A Review of Literature.Modelling recurrence and second cancer risks induced by proton therapy.The effect of radiation quality on the risks of second malignancies.Proton therapy in mediastinal Hodgkin lymphoma: moving from dosimetric prediction to clinical evidence.Modeling age-dependent radiation-induced second cancer risks and estimation of mutation rate: an evolutionary approach.Management and Prevention of Breast Cancer After Radiation to the Chest for Childhood, Adolescent, and Young Adulthood Malignancy.Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma.Breast dosimetry in transverse and longitudinal field MRI-Linac radiotherapy systems.Therapy-Related Late Adverse Events in Hodgkin’s Lymphoma
P2860
Q28384954-86790EF7-B346-4171-8007-CCC448858610Q28386127-FE48A2DD-F502-49C8-AEB6-8D003B1FC98FQ30368547-876F4003-B375-4E72-A618-8F28A885FDC8Q33406827-6D9BDA32-EA4C-4384-A63A-FF621B35CCB8Q33549627-029B2236-77F2-4058-A85C-7FB7369D80CDQ33579820-E84AC49C-1093-40F9-B10E-C303F99CD6FEQ34392159-C29A68DE-C7F5-433E-AA74-9352FD0557FBQ34604460-93764A7E-24AE-4FE7-88DC-E44ED90C6999Q34822846-6129DDFF-EE42-4B45-99F5-A00F2C831B52Q35112046-9E52EA6E-E13C-4A0D-8B76-90013253AA3AQ36051494-9155A02D-9435-4D5A-BAEA-EF39CF0236FBQ36189255-75DB0DD9-0B31-48CE-BAC8-7EEC1E3061BDQ36412607-C274DF08-734D-4829-850E-447261BC2066Q36450854-0F2A8737-7044-40DB-A80E-D7446C0472B4Q36736612-1E21A008-E3C6-4E78-B752-A36C93A2F040Q36915223-B78492D2-2347-4A22-9AC7-16790EC47343Q37148163-B681940E-E4A0-442D-AE3C-F0942B8E8C1DQ37272805-4F9FCE4A-6100-4AFD-A588-06CF3B2E0D66Q37330672-7441806F-CADE-4C40-93D4-CE55E812BCF4Q37348243-0263C43E-CE96-43FD-983F-0191BD1CA1E6Q37617832-9E19BAD3-55E4-4F86-95EC-79EF4561A4D8Q38115238-8FA265DB-8640-4352-AADE-A15044050335Q38248237-0080E4C0-3066-4351-A39F-33E7381C5A24Q38790112-6472E208-472F-41F6-897E-4A95B11C2105Q38792217-0B9DC329-8A8C-4041-9D43-B1274925F484Q39280292-FD69D10F-F3CF-426D-B94D-2EBA15EE4D5AQ39668341-6BED0771-CB00-484A-B331-23BEBAD320ECQ40148445-9F62CA5C-3E39-4ECA-A314-7DFAA67142ACQ40747471-E3802FF5-7F24-44F6-A577-51431B7F7B15Q41153190-0330A1F3-7394-469F-A878-3A1C2F76286EQ41835022-8FAC835C-8EE0-4586-8333-AE235CBC12F6Q47309291-3385A957-D0CE-412A-9194-81FD81535F36Q47714623-33122053-07D3-440E-9F5E-94EDBB2A03BDQ50088505-8A76A5B9-4B76-4C5E-A405-1C8266525D94Q51010979-9D6E9514-E596-4918-BD7D-73F34F720A04Q51279958-F9F4D4AE-F39D-46E6-ACD3-66F0C2FC2464Q52715715-4B8EBD6F-D70B-4874-A0C1-F8033F279F3DQ53241145-DC39E81A-1F5C-48AD-92A8-C0FA56911B31Q53321007-C4A92A61-D7EA-44E1-9E82-EB35E930F92EQ58920329-42409A55-A3BE-4B28-8BCB-DF69362F79CF
P2860
Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Individualized estimates of se ...... therapy for Hodgkin lymphoma.
@en
Individualized estimates of se ...... therapy for Hodgkin lymphoma.
@nl
type
label
Individualized estimates of se ...... therapy for Hodgkin lymphoma.
@en
Individualized estimates of se ...... therapy for Hodgkin lymphoma.
@nl
prefLabel
Individualized estimates of se ...... therapy for Hodgkin lymphoma.
@en
Individualized estimates of se ...... therapy for Hodgkin lymphoma.
@nl
P2093
P356
P1433
P1476
Individualized estimates of se ...... therapy for Hodgkin lymphoma.
@en
P2093
David C Hodgson
David J Brenner
Eng-Siew Koh
Melania Pintilie
Mostafa Heydarian
Rainer K Sachs
Tu Huan Tran
P2860
P304
P356
10.1002/CNCR.23081
P407
P577
2007-12-01T00:00:00Z